WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase its range of interventional products at the 53rd European Renal, Dialysis and Transplant Congress in Vienna on May 21 - 24, 2016.
During the event, Teleflex will showcase the ARROW-ClarkTM VectorFlowTM Hemodialysis Catheter. Designed for optimum performance, the ARROW-ClarkTM VectorFlowTM Catheter (available in both retrograde and antegrade insertion platforms) is a tunneled hemodialysis catheter with symmetrical tip that is designed to reduce loss of lock solution (a contributing factor in reducing the risk of thrombus adherence), give sustained high flows, minimize recirculation and reduce the risk of platelet damage resulting from shear stress.
During the event, Teleflex will showcase the ARROW-ClarkTM VectorFlowTM Hemodialysis Catheter. Designed for optimum performance, the ARROW-ClarkTM VectorFlowTM Catheter (available in both retrograde and antegrade insertion platforms) is a tunneled hemodialysis catheter with symmetrical tip that is designed to reduce loss of lock solution (a contributing factor in reducing the risk of thrombus adherence), give sustained high flows, minimize recirculation and reduce the risk of platelet damage resulting from shear stress.
